Navigation Links
Einstein & Montefiore present research at American Diabetes Association Scientific Sessions
Date:6/9/2014

June 9, 2014 (BRONX, NY) Investigators at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center will present their latest research at the American Diabetes Association's 74th Scientific Sessions. Einstein-Montefiore scientists and clinicians are participating in nearly three dozen presentations, sessions and symposia during the five-day meeting. They will address a range of basic, translational and clinical research topicsfrom medication adherence in adolescents and the impact on resveratrol and vitamin D on insulin resistance to epigenetic and genetic triggers for the disease. ADA will takes place June 13-17 at the Moscone Center in San Francisco, California.

Among the highlights are symposia featuring:

  • Jill Crandall, M.D., professor of clinical medicine at Einstein and attending physician, endocrinology at Montefiore, on the most recent findings from the ongoing Diabetes Prevention Program Outcomes Study (Mon., June 16 at 8:00 a.m.)

  • Maureen Charron, Ph.D., professor of biochemistry at Einstein, on the role of glucagon in metabolic homeostasis (Fri., June 13 at 2:00 p.m.)

  • Rajat Singh, M.D., assistant professor of medicine at Einstein, on the role of autophagy in diabetes (Sat., June 14 at 2:15 p.m.)

  • Judith Wylie-Rosett, Ed.D., division head, health promotion and nutrition research, department of epidemiology and population health at Einstein, on better approaches to counseling weight loss among obese patients (Tues., June 17 at 7:30 a.m.)

Poster and oral presentations will include:

  • Vitamin D Repletion Reduces Adipose Tissue Fibrosis and Improves Insulin. Oral presentation by Akankasha Goyal, M.D., a research fellow in the lab of Meredith Hawkins, M.D., professor of medicine at Einstein and attending physician, endocrinology at Montefiore. Abstract #OR-90, IA-OR02: Adipose Tissue Development and Metabolic Signaling. Sat., June 14, 8:00-10:00 a.m. W-2002 (West Building)

  • Distress and Diabetes Treatment Adherence: A Mediating Role for Perceived Control in Adults with Type 2 Diabetes. Poster presented by Jeffrey S. Gonzalez, Ph.D., assistant professor of medicine and epidemiology & population heath at Einstein. Poster #822, GPS01: Saturday General Poster Session. Sat., June 14, 11:30 a.m.-1:30 p.m. Poster Hall (Hall D-North)

  • Resveratrol Improves Insulin Resistance without Affecting Muscle Mitochondria in Overweight Humans. Oral presentation by Roger Maginley, M.D., a research fellow in the lab of Dr. Hawkins. Abstract #144, AC-OR05: Hypoglycemia Brain, Muscle, Heart and Opioids. Sun., June 15, 8:00-10:00 a.m., N-132 (North Building)

  • Relationship of Self-Esteem to Glycemic Control amongst Minority Adolescents with Type 1 Diabetes. Poster presented by Joslyn Kenowitz, Ph.D. student in lab of Dr. Gonzalez, working in collaboration with Rubina Heptulla, M.B.B.S., chief of pediatric endocrinology at Einstein and Montefiore. Poster #64-LB, Late Breaking Poster Session. Sun., June 15, 12:00-2:00 p.m., Poster Hall (Hall D-North)

  • Exposure to a Maternal High Fat Milieu Alters Hepatic and White Adipose Epigenome in Mice. Poster presented by Maureen Charron, Ph.D., professor of biochemistry at Einstein. Poster #1806, GPS03: Monday General Poster Session. Mon., June 16, 12:00-2:00 p.m., Poster Hall (Hall D-North).

  • FTO Genetic Variants, Dietary Intakes, and Adiposity: Results from Over 16,000 Children and Adolescents. Oral presentation by Qibin Qi, Ph.D., assistant professor of epidemiology and population health at Einstein. Abstract #382-OR, CT-OR14: ADA Presidents Oral Session. Tues., June 17, 9:45-11:45 a.m., N-134 (North Building)

Einstein-Montefiore investigators are available to speak about their research and other topics of interest upon request.


'/>"/>

Contact: Deirdre Branley
sciencenews@einstein.yu.edu
718-430-3101
Albert Einstein College of Medicine
Source:Eurekalert

Related medicine news :

1. Feinstein Institute researcher publishes new perspective on sepsis
2. Einstein helps establish $28 million consortium to find ebola treatment
3. Registration open for the Weinstein Cardiovascular Conference
4. Feinstein Institute Researcher Joins International Partnership in Neuroscience Research
5. Feinstein Institute researchers show a genetic overlap in schizophrenia and cognitive ability
6. Feinstein Researcher Receives 2013 Best of Manhasset Award
7. Feinstein Institute Encourages Science Education for NY Area Middle and High School Students
8. Einstein researchers lead panels at NIH Aging and Chronic Disease Symposium on Geroscience
9. How does aging affect cancer? Einstein awarded $2.8m grant to answer NCI provocative question
10. Albert Einstein Cancer Center begins 40th year of continuous NIH support with $17 million grant
11. Feinstein Institute Researcher Organizes LI Alzheimer’s Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... MYOLYN, a medical technology company dedicated ... received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two ... devices are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... A stressful ... at work can also decrease overall productivity and performance in the workplace. The goal ... , During the last few weeks of April, Clearview Resolution Services will be shutting ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... instrument solutions, announces the continuation of its strategic partnership with and platinum sponsorship ... developing nations in the safe and effective management of complex spine deformity cases, ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
Breaking Medicine Technology: